Thomas R. Kuhn - 02 Jan 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role: Director, Vice Chairman
Signature: s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol: ATEX
Transactions as of: 02 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2024, 17:52:40 UTC
Previous filing: 04 Jan 2024
Next filing: 17 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATEX	Common Stock	Award	$0	+3,898		$0.000000	3,898	02 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATEX	Stock Option (Right to Buy)	Award	$0	+58,998		$0.000000	58,998	02 Jan 2024	Common Stock	58,998	$33.62	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock vests in full on August 7, 2024.
F2	Options awarded in connection with director's appointment to the Board as Vice Chairman. For further information see the Anterix Inc. Form 8-K filed with the Securities Exchange Commission on January 4, 2024.
F3	1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter.